Altered gene expression profile in ovarian follicle in rats treated with indomethacin and RU486
It is well-known that indomethacin (the cyclooxygenase 1 & 2 inhibitor) and RU486 (or mifepristone, the progesterone receptor antagonist) block follicular rupture in rats. To characterize genetic alterations in unruptured follicles, gene expression profiles in ovarian follicle were analyzed in i...
Gespeichert in:
Veröffentlicht in: | Journal of toxicological sciences 2015/06/01, Vol.40(3), pp.413-425 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 425 |
---|---|
container_issue | 3 |
container_start_page | 413 |
container_title | Journal of toxicological sciences |
container_volume | 40 |
creator | Tsubota, Kenjiro Kanki, Masayuki Noto, Takahisa Nakatsuji, Shunji Oishi, Yuji Matsumoto, Masahiro Nakayama, Hiroyuki |
description | It is well-known that indomethacin (the cyclooxygenase 1 & 2 inhibitor) and RU486 (or mifepristone, the progesterone receptor antagonist) block follicular rupture in rats. To characterize genetic alterations in unruptured follicles, gene expression profiles in ovarian follicle were analyzed in indomethacin- and RU486-treated female Sprague-Dawley rats. Ovaries are collected at 22:00 on the proestrus day and 10:00 on the following estrus day after a single dose of indomethacin and RU486. Histopathologically, changes depicting responses to LH surge were observed in ovaries, uteri and vagina. Total RNA was extracted from pre-ovulatory follicles or unruptured follicles collected by laser microdissection and analyzed by Genechip®. Among genes showing statistically significant changes compared to control groups, following changes were considered relevant to induction of unruptured follicles. In indomethacin-treated rats, Wnt4 was down-regulated, suggesting effect on tissue integrity and steroid genesis. In RU486-treated rats, Adamts1, Adamts9, Edn2, Ednra, Lyve1, Plat, and Pparg were down-regulated. These changes suggest effects on proteolysis for extra cellular matrix or surrounding tissue (Adamts1 & 9, and Plat), constriction of smooth muscle surrounding follicles (Edn2, Ednra, and Pparg), follicular fluid (Lyve1), and angiogenesis (Pparg). Down-regulation of angiogenesis related genes (Angpt2, Hmox1, and Vegfa) was observed in both treatment groups. Here, we clarify genetic alterations induced by the inhibition of cyclooxygenase or progesterone receptor. |
doi_str_mv | 10.2131/jts.40.413 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1765992356</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1681264747</sourcerecordid><originalsourceid>FETCH-LOGICAL-c528t-3643b15bd871a609876760ebbc0c62a71f3d2ed47f4d493f098d24e65a2bdc4d3</originalsourceid><addsrcrecordid>eNqFkctKAzEUhoMoWi8bH0AG3IgwNfdkFi5EvIEgiK5DJjljp0xnapJ6eXtTWrtw4yrw58vHOfkROiZ4TAkjF9MUxxyPOWFbaES0xiWrdLWNRphpXRIm8B7aj3GKMVVY8F20R0WlKMVkhMxVlyCAL96ghwK-5gFibIe-mIehaTso2r4YPmxobV80Q9e1bpUFm2KRAtiU3362aZJDP8wgTazL17b3xfMr1_IQ7TS2i3C0Pg_Q6-3Ny_V9-fh093B99Vg6QXUqmeSsJqL2WhErcaWVVBJDXTvsJLWKNMxT8Fw13POKNZnwlIMUltbecc8O0NnKm-d-X0BMZtZGB11nexgW0RAlRVVRJuT_qNSESq64yujpH3Q6LEKfF8lCIXSeUy-F5yvKhSHGAI2Zh3Zmw7ch2CwbMrkhw7HJDWX4ZK1c1DPwG_S3kgxcroBpTPYNNoANafn5vy62Fm5yN7HBQM9-AKhCoRs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1755898786</pqid></control><display><type>article</type><title>Altered gene expression profile in ovarian follicle in rats treated with indomethacin and RU486</title><source>J-STAGE Free</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Tsubota, Kenjiro ; Kanki, Masayuki ; Noto, Takahisa ; Nakatsuji, Shunji ; Oishi, Yuji ; Matsumoto, Masahiro ; Nakayama, Hiroyuki</creator><creatorcontrib>Tsubota, Kenjiro ; Kanki, Masayuki ; Noto, Takahisa ; Nakatsuji, Shunji ; Oishi, Yuji ; Matsumoto, Masahiro ; Nakayama, Hiroyuki</creatorcontrib><description>It is well-known that indomethacin (the cyclooxygenase 1 & 2 inhibitor) and RU486 (or mifepristone, the progesterone receptor antagonist) block follicular rupture in rats. To characterize genetic alterations in unruptured follicles, gene expression profiles in ovarian follicle were analyzed in indomethacin- and RU486-treated female Sprague-Dawley rats. Ovaries are collected at 22:00 on the proestrus day and 10:00 on the following estrus day after a single dose of indomethacin and RU486. Histopathologically, changes depicting responses to LH surge were observed in ovaries, uteri and vagina. Total RNA was extracted from pre-ovulatory follicles or unruptured follicles collected by laser microdissection and analyzed by Genechip®. Among genes showing statistically significant changes compared to control groups, following changes were considered relevant to induction of unruptured follicles. In indomethacin-treated rats, Wnt4 was down-regulated, suggesting effect on tissue integrity and steroid genesis. In RU486-treated rats, Adamts1, Adamts9, Edn2, Ednra, Lyve1, Plat, and Pparg were down-regulated. These changes suggest effects on proteolysis for extra cellular matrix or surrounding tissue (Adamts1 & 9, and Plat), constriction of smooth muscle surrounding follicles (Edn2, Ednra, and Pparg), follicular fluid (Lyve1), and angiogenesis (Pparg). Down-regulation of angiogenesis related genes (Angpt2, Hmox1, and Vegfa) was observed in both treatment groups. Here, we clarify genetic alterations induced by the inhibition of cyclooxygenase or progesterone receptor.</description><identifier>ISSN: 0388-1350</identifier><identifier>EISSN: 1880-3989</identifier><identifier>DOI: 10.2131/jts.40.413</identifier><identifier>PMID: 25972201</identifier><language>eng</language><publisher>Japan: The Japanese Society of Toxicology</publisher><subject>Animals ; Cyclooxygenase Inhibitors - pharmacology ; Down-Regulation - drug effects ; Extracellular Matrix - metabolism ; Female ; Gene expression profiling ; Gene Expression Regulation, Developmental - drug effects ; Hormone Antagonists - pharmacology ; Indomethacin ; Indomethacin - pharmacology ; Mifepristone - pharmacology ; Neovascularization, Physiologic - drug effects ; Neovascularization, Physiologic - genetics ; Ovarian Follicle ; Proteolysis - drug effects ; Rats, Sprague-Dawley ; Receptors, Progesterone - antagonists & inhibitors ; RU486 ; Transcriptome - drug effects ; Unruptured follicle</subject><ispartof>The Journal of Toxicological Sciences, 2015/06/01, Vol.40(3), pp.413-425</ispartof><rights>2015 The Japanese Society of Toxicology</rights><rights>Copyright Japan Science and Technology Agency 2015</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c528t-3643b15bd871a609876760ebbc0c62a71f3d2ed47f4d493f098d24e65a2bdc4d3</citedby><cites>FETCH-LOGICAL-c528t-3643b15bd871a609876760ebbc0c62a71f3d2ed47f4d493f098d24e65a2bdc4d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25972201$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tsubota, Kenjiro</creatorcontrib><creatorcontrib>Kanki, Masayuki</creatorcontrib><creatorcontrib>Noto, Takahisa</creatorcontrib><creatorcontrib>Nakatsuji, Shunji</creatorcontrib><creatorcontrib>Oishi, Yuji</creatorcontrib><creatorcontrib>Matsumoto, Masahiro</creatorcontrib><creatorcontrib>Nakayama, Hiroyuki</creatorcontrib><title>Altered gene expression profile in ovarian follicle in rats treated with indomethacin and RU486</title><title>Journal of toxicological sciences</title><addtitle>J Toxicol Sci</addtitle><description>It is well-known that indomethacin (the cyclooxygenase 1 & 2 inhibitor) and RU486 (or mifepristone, the progesterone receptor antagonist) block follicular rupture in rats. To characterize genetic alterations in unruptured follicles, gene expression profiles in ovarian follicle were analyzed in indomethacin- and RU486-treated female Sprague-Dawley rats. Ovaries are collected at 22:00 on the proestrus day and 10:00 on the following estrus day after a single dose of indomethacin and RU486. Histopathologically, changes depicting responses to LH surge were observed in ovaries, uteri and vagina. Total RNA was extracted from pre-ovulatory follicles or unruptured follicles collected by laser microdissection and analyzed by Genechip®. Among genes showing statistically significant changes compared to control groups, following changes were considered relevant to induction of unruptured follicles. In indomethacin-treated rats, Wnt4 was down-regulated, suggesting effect on tissue integrity and steroid genesis. In RU486-treated rats, Adamts1, Adamts9, Edn2, Ednra, Lyve1, Plat, and Pparg were down-regulated. These changes suggest effects on proteolysis for extra cellular matrix or surrounding tissue (Adamts1 & 9, and Plat), constriction of smooth muscle surrounding follicles (Edn2, Ednra, and Pparg), follicular fluid (Lyve1), and angiogenesis (Pparg). Down-regulation of angiogenesis related genes (Angpt2, Hmox1, and Vegfa) was observed in both treatment groups. Here, we clarify genetic alterations induced by the inhibition of cyclooxygenase or progesterone receptor.</description><subject>Animals</subject><subject>Cyclooxygenase Inhibitors - pharmacology</subject><subject>Down-Regulation - drug effects</subject><subject>Extracellular Matrix - metabolism</subject><subject>Female</subject><subject>Gene expression profiling</subject><subject>Gene Expression Regulation, Developmental - drug effects</subject><subject>Hormone Antagonists - pharmacology</subject><subject>Indomethacin</subject><subject>Indomethacin - pharmacology</subject><subject>Mifepristone - pharmacology</subject><subject>Neovascularization, Physiologic - drug effects</subject><subject>Neovascularization, Physiologic - genetics</subject><subject>Ovarian Follicle</subject><subject>Proteolysis - drug effects</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Progesterone - antagonists & inhibitors</subject><subject>RU486</subject><subject>Transcriptome - drug effects</subject><subject>Unruptured follicle</subject><issn>0388-1350</issn><issn>1880-3989</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkctKAzEUhoMoWi8bH0AG3IgwNfdkFi5EvIEgiK5DJjljp0xnapJ6eXtTWrtw4yrw58vHOfkROiZ4TAkjF9MUxxyPOWFbaES0xiWrdLWNRphpXRIm8B7aj3GKMVVY8F20R0WlKMVkhMxVlyCAL96ghwK-5gFibIe-mIehaTso2r4YPmxobV80Q9e1bpUFm2KRAtiU3362aZJDP8wgTazL17b3xfMr1_IQ7TS2i3C0Pg_Q6-3Ny_V9-fh093B99Vg6QXUqmeSsJqL2WhErcaWVVBJDXTvsJLWKNMxT8Fw13POKNZnwlIMUltbecc8O0NnKm-d-X0BMZtZGB11nexgW0RAlRVVRJuT_qNSESq64yujpH3Q6LEKfF8lCIXSeUy-F5yvKhSHGAI2Zh3Zmw7ch2CwbMrkhw7HJDWX4ZK1c1DPwG_S3kgxcroBpTPYNNoANafn5vy62Fm5yN7HBQM9-AKhCoRs</recordid><startdate>20150601</startdate><enddate>20150601</enddate><creator>Tsubota, Kenjiro</creator><creator>Kanki, Masayuki</creator><creator>Noto, Takahisa</creator><creator>Nakatsuji, Shunji</creator><creator>Oishi, Yuji</creator><creator>Matsumoto, Masahiro</creator><creator>Nakayama, Hiroyuki</creator><general>The Japanese Society of Toxicology</general><general>Japan Science and Technology Agency</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7ST</scope><scope>7U7</scope><scope>C1K</scope><scope>SOI</scope><scope>7X8</scope></search><sort><creationdate>20150601</creationdate><title>Altered gene expression profile in ovarian follicle in rats treated with indomethacin and RU486</title><author>Tsubota, Kenjiro ; Kanki, Masayuki ; Noto, Takahisa ; Nakatsuji, Shunji ; Oishi, Yuji ; Matsumoto, Masahiro ; Nakayama, Hiroyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c528t-3643b15bd871a609876760ebbc0c62a71f3d2ed47f4d493f098d24e65a2bdc4d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Cyclooxygenase Inhibitors - pharmacology</topic><topic>Down-Regulation - drug effects</topic><topic>Extracellular Matrix - metabolism</topic><topic>Female</topic><topic>Gene expression profiling</topic><topic>Gene Expression Regulation, Developmental - drug effects</topic><topic>Hormone Antagonists - pharmacology</topic><topic>Indomethacin</topic><topic>Indomethacin - pharmacology</topic><topic>Mifepristone - pharmacology</topic><topic>Neovascularization, Physiologic - drug effects</topic><topic>Neovascularization, Physiologic - genetics</topic><topic>Ovarian Follicle</topic><topic>Proteolysis - drug effects</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Progesterone - antagonists & inhibitors</topic><topic>RU486</topic><topic>Transcriptome - drug effects</topic><topic>Unruptured follicle</topic><toplevel>online_resources</toplevel><creatorcontrib>Tsubota, Kenjiro</creatorcontrib><creatorcontrib>Kanki, Masayuki</creatorcontrib><creatorcontrib>Noto, Takahisa</creatorcontrib><creatorcontrib>Nakatsuji, Shunji</creatorcontrib><creatorcontrib>Oishi, Yuji</creatorcontrib><creatorcontrib>Matsumoto, Masahiro</creatorcontrib><creatorcontrib>Nakayama, Hiroyuki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Environment Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Environment Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of toxicological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tsubota, Kenjiro</au><au>Kanki, Masayuki</au><au>Noto, Takahisa</au><au>Nakatsuji, Shunji</au><au>Oishi, Yuji</au><au>Matsumoto, Masahiro</au><au>Nakayama, Hiroyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Altered gene expression profile in ovarian follicle in rats treated with indomethacin and RU486</atitle><jtitle>Journal of toxicological sciences</jtitle><addtitle>J Toxicol Sci</addtitle><date>2015-06-01</date><risdate>2015</risdate><volume>40</volume><issue>3</issue><spage>413</spage><epage>425</epage><pages>413-425</pages><issn>0388-1350</issn><eissn>1880-3989</eissn><abstract>It is well-known that indomethacin (the cyclooxygenase 1 & 2 inhibitor) and RU486 (or mifepristone, the progesterone receptor antagonist) block follicular rupture in rats. To characterize genetic alterations in unruptured follicles, gene expression profiles in ovarian follicle were analyzed in indomethacin- and RU486-treated female Sprague-Dawley rats. Ovaries are collected at 22:00 on the proestrus day and 10:00 on the following estrus day after a single dose of indomethacin and RU486. Histopathologically, changes depicting responses to LH surge were observed in ovaries, uteri and vagina. Total RNA was extracted from pre-ovulatory follicles or unruptured follicles collected by laser microdissection and analyzed by Genechip®. Among genes showing statistically significant changes compared to control groups, following changes were considered relevant to induction of unruptured follicles. In indomethacin-treated rats, Wnt4 was down-regulated, suggesting effect on tissue integrity and steroid genesis. In RU486-treated rats, Adamts1, Adamts9, Edn2, Ednra, Lyve1, Plat, and Pparg were down-regulated. These changes suggest effects on proteolysis for extra cellular matrix or surrounding tissue (Adamts1 & 9, and Plat), constriction of smooth muscle surrounding follicles (Edn2, Ednra, and Pparg), follicular fluid (Lyve1), and angiogenesis (Pparg). Down-regulation of angiogenesis related genes (Angpt2, Hmox1, and Vegfa) was observed in both treatment groups. Here, we clarify genetic alterations induced by the inhibition of cyclooxygenase or progesterone receptor.</abstract><cop>Japan</cop><pub>The Japanese Society of Toxicology</pub><pmid>25972201</pmid><doi>10.2131/jts.40.413</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0388-1350 |
ispartof | The Journal of Toxicological Sciences, 2015/06/01, Vol.40(3), pp.413-425 |
issn | 0388-1350 1880-3989 |
language | eng |
recordid | cdi_proquest_miscellaneous_1765992356 |
source | J-STAGE Free; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Free Full-Text Journals in Chemistry |
subjects | Animals Cyclooxygenase Inhibitors - pharmacology Down-Regulation - drug effects Extracellular Matrix - metabolism Female Gene expression profiling Gene Expression Regulation, Developmental - drug effects Hormone Antagonists - pharmacology Indomethacin Indomethacin - pharmacology Mifepristone - pharmacology Neovascularization, Physiologic - drug effects Neovascularization, Physiologic - genetics Ovarian Follicle Proteolysis - drug effects Rats, Sprague-Dawley Receptors, Progesterone - antagonists & inhibitors RU486 Transcriptome - drug effects Unruptured follicle |
title | Altered gene expression profile in ovarian follicle in rats treated with indomethacin and RU486 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T16%3A11%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Altered%20gene%20expression%20profile%20in%20ovarian%20follicle%20in%20rats%20treated%20with%20indomethacin%20and%20RU486&rft.jtitle=Journal%20of%20toxicological%20sciences&rft.au=Tsubota,%20Kenjiro&rft.date=2015-06-01&rft.volume=40&rft.issue=3&rft.spage=413&rft.epage=425&rft.pages=413-425&rft.issn=0388-1350&rft.eissn=1880-3989&rft_id=info:doi/10.2131/jts.40.413&rft_dat=%3Cproquest_cross%3E1681264747%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1755898786&rft_id=info:pmid/25972201&rfr_iscdi=true |